<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01793571</url>
  </required_header>
  <id_info>
    <org_study_id>NL40460.094.12</org_study_id>
    <nct_id>NCT01793571</nct_id>
  </id_info>
  <brief_title>Pilot Study on the Effectiveness of a TAP-block for Inguinal Hernia Repair</brief_title>
  <official_title>A Pilot Study on the Effectiveness of the Echoguided Transversus Abdominis Plane Block During Inguinal Hernia Repair Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Westfriesgasthuis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Westfriesgasthuis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An prospective double blinded randomised trial,whether the use of an perioperative echoguided
      unilateral TAP block has an superior effect on postoperative pain after open hernia inguinal
      repair compared to wound infiltration with a long acting local anesthetic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hernia inguinal repair is the most common operation performed by general surgeons in the
      Netherlands. On of the most common complications after hernia repair is postoperative and
      chronic pain. Postoperative pain is an expected but undesirable effect after an operation,
      which can result in an prolonged hospital stay or longer time to return to full normal daily
      activities. There are indications that an insufficient treatment of postoperative pain is a
      risk factor for persistent or chronic pain after open inguinal hernia repair. Chronic pain is
      not uncommon after hernia repair, with an incidence of 11%.

      The objective of this study is to determine, whether the use of an perioperative echo guided
      unilateral TAP block has an superior effect on postoperative pain after open hernia inguinal
      repair compared to wound infiltration with a long acting local anesthetic. There will be no
      further analysis in this study regarding the incidence of open hernia inguinal repair and
      chronic pain.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary objective is to analyse, differences in pain scores between the 2 groups until 48 hours after the operation</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to to first use of intravenous morfine</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the total amount of titrated postoperative morfine</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of tramadol at home</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of nausea and vomiting</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Hernia Inguinal</condition>
  <arm_group>
    <arm_group_label>TAP block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 ml Levobupivacaine 0,5%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local wound infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 ml levobupivacaine 0,5%</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAP block</intervention_name>
    <description>2 groups, group A a TAP block with 20 ml of Levobupivacaine 0,5% and subcutaneous wound infiltration with 20 ml sodium chloride (to blind patient and physician) and group B, TAP block with 20 ml sodium chloride and subcutaneous wound infiltration with 20 ml Levobupivacaine 0,5% (to blind patient and physician)</description>
    <arm_group_label>TAP block</arm_group_label>
    <arm_group_label>Local wound infiltration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18 and 80 year, competent, elective surgical treatment, Body Mass Index
             (BMI) between 20-35.

        Exclusion Criteria:

          -  fever, a coagulation disorder, patients with kidney and liverfaillure, an infection at
             the place where the puncture place, preoperative use of narcotic and nonsteroidal
             antiinflammatory drugs.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens P Hering, Anesthesiologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Westfriesgasthuis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Westfriesgasthuis</name>
      <address>
        <city>Hoorn</city>
        <state>Noord-Holland</state>
        <zip>1620AR</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2013</study_first_submitted>
  <study_first_submitted_qc>February 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>February 14, 2013</last_update_submitted>
  <last_update_submitted_qc>February 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Westfriesgasthuis</investigator_affiliation>
    <investigator_full_name>Peter Dijkhuizen</investigator_full_name>
    <investigator_title>MPA Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Abdominal Muscles/Ultrasonography</keyword>
  <keyword>Adult</keyword>
  <keyword>Ambulatory Surgical Procedures</keyword>
  <keyword>Anesthetics, Local/Administration &amp; Dosage</keyword>
  <keyword>Levobupivacaine/Administration &amp; Dosage</keyword>
  <keyword>Levobupivacaine/Analogs &amp; Derivatives</keyword>
  <keyword>Hernia, Inguinal/Surgery</keyword>
  <keyword>Humans</keyword>
  <keyword>Nerve Block/Methods</keyword>
  <keyword>Pain Measurement/Methods</keyword>
  <keyword>Pain, Postoperative/Prevention &amp; Control</keyword>
  <keyword>Ultrasonography, Interventional</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

